Wird geladen...
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure
AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...
Gespeichert in:
| Veröffentlicht in: | World J Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/ https://ncbi.nlm.nih.gov/pubmed/25892862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|